Form 4: Jaguar Health Executive Pravin R Chaturvedi Reports Stock Transactions
SEC Form 4 Filing
Pravin R Chaturvedi, Chief Scientific Officer of Jaguar Health, Inc., reports the vesting and conversion of restricted stock units into common stock.
Summary
- On May 17, 2024, Pravin R Chaturvedi, the Chief Scientific Officer of Jaguar Health, Inc., reported a transaction involving restricted stock units.
- Specifically, 871 restricted stock units vested and were converted into 871 shares of common stock.
- These restricted stock units were initially approved on March 28, 2022, and vest in three equal annual installments starting May 17, 2023.
- The reported transaction reflects adjustments due to a 75-for-1 reverse stock split that occurred on January 23, 2023.
Sentiment
Score: 5
Explanation: The document is a routine regulatory filing related to stock transactions by an executive, and does not contain information that would significantly shift investor sentiment.
Industry Context
Form 4 filings are standard practice and provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- The vesting of restricted stock units dilutes existing shareholders' equity, although the impact is likely minimal given the relatively small number of shares involved.
Key Dates
| Date | Description |
|---|---|
| March 28, 2022 | Original approval date of the restricted stock units by the issuer's board of directors. |
| January 23, 2023 | Date of the 75-for-1 reverse stock split. |
| May 17, 2023 | Start date of the three equal annual installments for vesting of restricted stock units. |
| May 17, 2024 | Date of the reported transaction where 871 restricted stock units vested and converted into common stock. |
| May 21, 2024 | Date of signature on the Form 4 filing. |
Keywords
Jaguar Health, Pravin R Chaturvedi, insider trading, Form 4, restricted stock units, stock transaction, reverse stock split, JAGX, Chief Scientific Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.